TABLE I.
Analytic population | Non-analytic P9754 population | Non-analytic P9851 population | |
---|---|---|---|
Gender | |||
Male | 78 (52.3%) | 79 (60.8%) | 250 (54.2%) |
Female | 71 (47.7%) | 51 (39.2%) | 211 (45.8%) |
Race | |||
White | 107 (71.8%) | 89 (68.5%) | 336 (72.9%) |
Black | 21 (14.1%) | 20 (15.4%) | 58 (12.6%) |
Other | 15 (10.1%) | 15 (11.5%) | 52 (11.3%) |
Unknown | 6 (4.0%) | 6 (4.6%) | 15 (3.3%) |
Ethnicity | |||
Non-Hispanic | 90 (60.4%) | 97 (74.6%) | 381 (82.6%) |
Hispanic | 15 (10.1%) | 13 (10.0%) | 59 (12.8%) |
Unknown | 44 (29.5%) | 20 (15.4%) | 21 (4.6%) |
Median age (min–max) | 14.02 (4.72–28.40) | 14.38 (3.85–30.50) | 14.09 (0.18–33.17) |
<10 | 25 (16.8%) | 24 (18.5%) | 74 (16.0%) |
10–17 | 106 (71.1%) | 85 (65.4%) | 335 (72.7%) |
18+ | 18 (12.1%) | 21 (16.1%) | 52 (11.3%) |
Primary tumor site | |||
Extremity | 145 (97.3%) | 130 (100%) | 428 (92.8%) |
Pelvis | 2 (1.3%) | 0 | 22 (4.8%) |
Other | 2 (1.3%) | 0 | 11 (2.4%) |
Disease at diagnosis | |||
Non-metastatic | 135 (90.6%) | 130 (100%) | 371 (80.5%) |
Metastatic | 14 (9.4%) | 0 | 90 (19.5%) |